We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$565M
AUM Growth
+$18.6M
Cap. Flow
-$16.4M
Cap. Flow %
-2.91%
Top 10 Hldgs %
52.66%
Holding
41
New
8
Increased
7
Reduced
20
Closed
4

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$18.2M
2
HSIC icon
Henry Schein
HSIC
+$12.5M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.94M
4
HOLX
Hologic
HOLX
+$7.87M
5
QGEN icon
Qiagen
QGEN
+$7.8M

Top Sells

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$10.4M
2
PFE icon
Pfizer
PFE
+$8.78M
3
CNC icon
Centene
CNC
+$8.16M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$7.75M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
26
DELISTED
Hologic
HOLX
$7.86M 1.39%
+117,738
New +$7.87M
QGEN icon
27
Qiagen
QGEN
$8.35B
$7.74M 1.37%
+150,946
New +$7.8M
RIGL icon
28
Rigel Pharmaceuticals
RIGL
$734M
$7.4M 1.31%
170,555
+17,506
+11% +$661K
BMRN icon
29
BioMarin Pharmaceuticals
BMRN
$11.4B
$5.75M 1.02%
68,964
-22,750
-25% -$1.8M
SAGE
30
DELISTED
Sage Therapeutics
SAGE
$5.16M 0.91%
+90,738
New +$6.41M
JNJ icon
31
Johnson & Johnson
JNJ
$599B
$4.94M 0.88%
30,000
– –
PDCO
32
DELISTED
Patterson Companies, Inc.
PDCO
$4.31M 0.76%
+141,743
New +$4.77M
UHS icon
33
Universal Health Services
UHS
$9.12B
$4.28M 0.76%
29,211
+7,217
+33% +$1.09M
AUPH icon
34
Aurinia Pharmaceuticals
AUPH
$1.96B
$3.04M 0.54%
+234,916
New +$2.99M
NVAX icon
35
Novavax
NVAX
$1.3B
$2.89M 0.51%
+13,626
New +$2.5M
REGN icon
36
Regeneron Pharmaceuticals
REGN
$70.5B
$2.72M 0.48%
4,876
– –
LIVN icon
37
LivaNova
LIVN
$4.35B
$1.25M 0.22%
14,803
-126,680
-90% -$10.4M
BNTX icon
38
BioNTech
BNTX
$23.3B
– –
-54,000
Closed -$5.9M
CVAC
39
DELISTED
CureVac
CVAC
– –
-25,000
Closed -$2.29M
HCA icon
40
HCA Healthcare
HCA
$82.2B
– –
-29,690
Closed -$5.59M
ALXN
41
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-50,657
Closed -$7.75M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2021 Portfolio in Review

As of Q2 2021, Sector Gamma AS held 41 positions worth $565M, up 3.4% from $546M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sector Gamma AS's Q2 2021 filing shows 8 new, 7 increased, 20 reduced and 4 closed positions. Its largest new stake was Organon & Co: 552,232 shares worth $16.7M. The largest sale was LivaNova, an estimated $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2021 buy was Organon & Co: 552,232 shares worth $16.7M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q2 2021, an estimated $9.94M increase.
  • Sector Gamma AS's biggest Q2 2021 reduction was LivaNova, cutting an estimated $10.4M.
  • Sector Gamma AS fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $7.75M.
  • Sector Gamma AS's ten largest holdings make up 53% of its $565M portfolio in Q2 2021.
  • Sector Gamma AS opened 8 new positions and closed 4 in Q2 2021.
  • Sector Gamma AS's portfolio value rose 3.4% quarter-over-quarter to $565M.

Based on Sector Gamma AS's 13F filing for Q2 2021, filed 4 Aug 2021.